Second Affiliated Hospital, School of Medicine, Zhejiang University: Pancreatic Neoplasms trials

The registry lists 11 Pancreatic Neoplasms studies with Second Affiliated Hospital, School of Medicine, Zhejiang University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 4Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Hepatobiliary and Pancreatic Tumor BiobankNot yet recruitingNCT07344116
• Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisRecruitingNCT06822413
• Early-stage Detection of LIver, Biliary TRAct and PancReatic CancersRecruitingNCT06139042
• Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic CancerNot yet recruitingNCT06134765Phase 2
• Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic CancerRecruitingNCT03498326Phase 2
• Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic CancerCompletedNCT04977596
• Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic CancerCompletedNCT03750669Phase 3
• SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer PatientsTerminatedNCT03716596Phase 1
• Study of Sirolimus in Patients With Advanced Pancreatic CancerStatus unknownNCT03662412Phase 1/2
• Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic CancerCompletedNCT03469375
• Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)Status unknownNCT02461836Phase 2